[Jiangsu province coronary artery bypass grafting registry study: a report of 7 475 patients from 16 centers].

C Zang, H Ding, H W Jiang, X Cao, J K Wang, X Chen, Y F Shao, R Wang
{"title":"[Jiangsu province coronary artery bypass grafting registry study: a report of 7 475 patients from 16 centers].","authors":"C Zang, H Ding, H W Jiang, X Cao, J K Wang, X Chen, Y F Shao, R Wang","doi":"10.3760/cma.j.cn112139-20260209-00064","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b> To evaluate coronary artery bypass grafting (CABG) in Jiangsu Provinc registry database from 2019 to 2024. <b>Methods:</b> This is a multicenter retrospective registry study. Data of the CABG registry database in Jiangsu Province from January 2019 to December 2024 were retrospectively collected. A total of 7 475 patients who underwent isolated CABG from 16 medical centers. There were 5 484 males and 1 991 females, with an age of (66.7±9.2) years (range: 23 to 92 years) and a body mass index of (24.6±3.2) kg/m<sup>2</sup> (range:15.5 to 39.6 kg/m<sup>2</sup>).Preoperative risk factors, medical history, cardiac function were analyzed (New York Heart Association classification), coronary artery disease, European Heart Surgery Risk Assessment System Ⅱ(EuroSCORE Ⅱ) score, whether CPB was used, whether arterial bridge was used, the number and flow of bridge vessels, postoperative stroke, myocardial infarction and mediastinal infection were analyzed. Independent sample <i>t</i>-test and <i>χ</i>² test were used to compare the differences in clinical data between patients undergoing on-pump coronary artery bypass grafting (ONCABG) and off-pump coronary artery bypass grafting (OPCAB). <b>Results:</b> Left main coronary artery disease was present in 2 181 cases (29.18%), three-vessel disease in 6 212 cases (83.10%), and left main coronary artery disease combined with three-vessel disease in 1 987 cases (26.58%). Left ventricular ejection fraction (LVEF)<50% was observed in 1 544 cases (20.66%), cardiac function class Ⅲ to Ⅳ in 2 654 cases (35.51%), and the EuroSCORE Ⅱ score was (<i>M</i>(IQR)) 1.28% (1.87%) (range: 0.8% to 39.4%). There were a total of 5 214 cases of ONCABG (69.75%) and 2 261 cases of OPCAB (30.25%). The left internal mammary artery (LIMA) was used in 6 407 cases (85.71%), with skeletonized LIMA in 2 949 cases (46.03%) and pedicled LIMA in 3 458 cases (53.97%). Sixteen centers used the radial artery as conduit material. The number of grafts per patient was 3.1±1.1 (range:1 to 7). The intraoperative cardiopulmonary bypass time was (106.0±34.9) min (range:22 to 310 min), and the aortic cross-clamp time was (76.9±26.2) min (range:20 to 205 min). There were 168 in-hospital deaths (2.25%). Reoperations in 110 cases (1.47%), including 86 cases of re-sternotomy for hemostasis and 24 cases of repeat revascularization. Perioperative complications: myocardial infarction 36 cases (0.48%), stroke 73 cases (0.98%), 274 cases of acute kidney injury after operation (3.67%), 100 cases (1.34%) of renal failure requiring dialysis 134 cases (1.79%) of mediastinal infection 6 450 cases were discharged for secondary prevention compared with OPCAB group, ONCABG group had a higher proportion of patients with smoking history, higher proportion of patients with hyperlipidemia, chronic lung disease, carotid artery stenosis, cardiac function Ⅲ to Ⅳ, history of Percutaneous Coronary Intervention higher EuroSCORE Ⅱ score, more left main trunk with three vessels disease, lower LVEF, higher proportion of intraoperative red suspension infusion; Postoperative acute kidney injury, new renal failure dialysis, secondary thoracotomy, stroke, poor incision healing, and in-hospital mortality were all increased (all <i>P</i><0.05). <b>Conclusions:</b> CABG registry database in Jiangsu Province generally operated well from 2019 to 2024. Compared with OPCAB group, ONCABG group patients had more severe preoperative conditions, higher postoperative complications and in-hospital mortality. Overall perioperative complications in Jiangsu Province were controlled close to or better than international advanced levels.</p>","PeriodicalId":60685,"journal":{"name":"中华外科杂志","volume":"64 7","pages":"793-798"},"PeriodicalIF":0.0000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华外科杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/cma.j.cn112139-20260209-00064","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To evaluate coronary artery bypass grafting (CABG) in Jiangsu Provinc registry database from 2019 to 2024. Methods: This is a multicenter retrospective registry study. Data of the CABG registry database in Jiangsu Province from January 2019 to December 2024 were retrospectively collected. A total of 7 475 patients who underwent isolated CABG from 16 medical centers. There were 5 484 males and 1 991 females, with an age of (66.7±9.2) years (range: 23 to 92 years) and a body mass index of (24.6±3.2) kg/m2 (range:15.5 to 39.6 kg/m2).Preoperative risk factors, medical history, cardiac function were analyzed (New York Heart Association classification), coronary artery disease, European Heart Surgery Risk Assessment System Ⅱ(EuroSCORE Ⅱ) score, whether CPB was used, whether arterial bridge was used, the number and flow of bridge vessels, postoperative stroke, myocardial infarction and mediastinal infection were analyzed. Independent sample t-test and χ² test were used to compare the differences in clinical data between patients undergoing on-pump coronary artery bypass grafting (ONCABG) and off-pump coronary artery bypass grafting (OPCAB). Results: Left main coronary artery disease was present in 2 181 cases (29.18%), three-vessel disease in 6 212 cases (83.10%), and left main coronary artery disease combined with three-vessel disease in 1 987 cases (26.58%). Left ventricular ejection fraction (LVEF)<50% was observed in 1 544 cases (20.66%), cardiac function class Ⅲ to Ⅳ in 2 654 cases (35.51%), and the EuroSCORE Ⅱ score was (M(IQR)) 1.28% (1.87%) (range: 0.8% to 39.4%). There were a total of 5 214 cases of ONCABG (69.75%) and 2 261 cases of OPCAB (30.25%). The left internal mammary artery (LIMA) was used in 6 407 cases (85.71%), with skeletonized LIMA in 2 949 cases (46.03%) and pedicled LIMA in 3 458 cases (53.97%). Sixteen centers used the radial artery as conduit material. The number of grafts per patient was 3.1±1.1 (range:1 to 7). The intraoperative cardiopulmonary bypass time was (106.0±34.9) min (range:22 to 310 min), and the aortic cross-clamp time was (76.9±26.2) min (range:20 to 205 min). There were 168 in-hospital deaths (2.25%). Reoperations in 110 cases (1.47%), including 86 cases of re-sternotomy for hemostasis and 24 cases of repeat revascularization. Perioperative complications: myocardial infarction 36 cases (0.48%), stroke 73 cases (0.98%), 274 cases of acute kidney injury after operation (3.67%), 100 cases (1.34%) of renal failure requiring dialysis 134 cases (1.79%) of mediastinal infection 6 450 cases were discharged for secondary prevention compared with OPCAB group, ONCABG group had a higher proportion of patients with smoking history, higher proportion of patients with hyperlipidemia, chronic lung disease, carotid artery stenosis, cardiac function Ⅲ to Ⅳ, history of Percutaneous Coronary Intervention higher EuroSCORE Ⅱ score, more left main trunk with three vessels disease, lower LVEF, higher proportion of intraoperative red suspension infusion; Postoperative acute kidney injury, new renal failure dialysis, secondary thoracotomy, stroke, poor incision healing, and in-hospital mortality were all increased (all P<0.05). Conclusions: CABG registry database in Jiangsu Province generally operated well from 2019 to 2024. Compared with OPCAB group, ONCABG group patients had more severe preoperative conditions, higher postoperative complications and in-hospital mortality. Overall perioperative complications in Jiangsu Province were controlled close to or better than international advanced levels.

[江苏省冠状动脉搭桥术登记研究:16个中心7475例患者报告]。
目的:对江苏省2019 - 2024年冠状动脉旁路移植术(CABG)登记数据库进行评价。方法:这是一项多中心回顾性登记研究。回顾性收集2019年1月至2024年12月江苏省CABG登记数据库数据。共有来自16个医疗中心的7475名患者接受了孤立的冠脉搭桥。男性5 484人,女性1 991人,年龄(66.7±9.2)岁(范围:23 ~ 92岁),体重指数(24.6±3.2)kg/m²(范围:15.5 ~ 39.6 kg/m²)。分析术前危险因素、病史、心功能(纽约心脏协会分类)、冠状动脉疾病、欧洲心脏手术风险评估系统Ⅱ(EuroSCOREⅡ)评分、是否使用CPB、是否使用动脉桥、桥血管数量及流量、术后卒中、心肌梗死、纵隔感染。采用独立样本t检验和χ 2检验比较有泵式冠状动脉旁路移植术(ONCABG)和无泵式冠状动脉旁路移植术(OPCAB)患者临床资料的差异。结果:冠状动脉左主干病变2 181例(29.18%),三支病变6 212例(83.10%),冠状动脉左主干病变合并三支病变1 1987例(26.58%)。结论:2019 - 2024年江苏省CABG登记数据库总体运行良好。与OPCAB组相比,ONCABG组患者术前病情更严重,术后并发症和住院死亡率更高。江苏省围手术期并发症总体控制接近或优于国际先进水平。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.80
自引率
0.00%
发文量
20861
期刊介绍: Chinese Journal of Surgery|Chin J Surg (monthly) is a high-level medical science and technology journal approved by the General Administration of Press and Publication of the People's Republic of China, under the supervision of the China Association for Science and Technology, and organised by the Chinese Medical Association for domestic and international public circulation. It was founded in January 1951, and is published on the basis of the Journal of Chinese Surgery. The Journal is aimed at senior and intermediate surgeons and related researchers, mainly reporting the leading scientific research results and clinical experience in the field of surgery, as well as the basic theoretical research that has a guiding effect on the clinical work of surgery. Chinese Journal of Surgery|Chin J Surg is committed to reflecting the major research progress in the field of surgery in China and promoting academic exchanges at home and abroad. The main columns include thesis, meta-analysis, review, expert forum, synthesis, case report, diagnosis and treatment experience, technical exchange, clinical case discussion, academic controversy, and special lectures, etc. The journal has been accepted by the National Academy of Medicine of the United States. The journal has been included in many famous databases at home and abroad, such as the Biomedical Analysis and Online Retrieval System (MEDLINE) of the U.S. National Library of Medicine.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书